Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus
G Kirtschig1,2, K Becker3, A Günthert4
1Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
Summary
Lichen sclerosus (LS) is an inflammatory skin condition. Early diagnosis and treatment, often with potent topical steroids, can prevent scarring, with circumcision being an option for mild cases in males.
Area of Science:
- Dermatology
- Inflammatory skin diseases
Background:
- Lichen sclerosus (LS) is a chronic inflammatory dermatosis primarily affecting the anogenital region.
- Delayed diagnosis of LS can lead to significant scarring and long-term complications.
- Expert medical evaluation is crucial for accurate and timely diagnosis of LS.
Purpose of the Study:
- To provide an overview of lichen sclerosus diagnosis and management.
- To emphasize the importance of early intervention in lichen sclerosus.
- To outline current treatment standards and preventive measures for LS.
Main Methods:
- Clinical diagnosis is the primary method for identifying lichen sclerosus.
- Biopsies are reserved for specific diagnostic uncertainties.
- Review of established treatment guidelines and clinical experience.
Main Results:
- Potent topical corticosteroids are the established gold standard for LS treatment.
- Circumcision can be curative for mild to moderate LS in boys and men.
- Identification and avoidance of potential triggers are recommended.
Conclusions:
- Prompt medical attention for suspected lichen sclerosus is essential for optimal outcomes.
- Effective management strategies exist, including topical steroids and, in specific cases, circumcision.
- Preventive measures and trigger avoidance play a role in managing lichen sclerosus.
